Elicio Therapeutics (ELTX) Company Overview

Profile

Full Name:

Elicio Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 5, 2021

Indexes:

Not included

Description:

Elicio Therapeutics (ELTX) is a biotechnology company focused on developing innovative cancer treatments. They use a unique platform to create therapies that stimulate the immune system, helping the body fight cancer more effectively. Their goal is to improve patient outcomes and advance cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 2, 2023

Analyst ratings

Recent major analysts updates

Oct 31, 24 Jones Trading
Buy
Aug 23, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy
May 22, 24 HC Wainwright & Co.
Buy
May 1, 24 HC Wainwright & Co.
Buy
Apr 1, 24 Oppenheimer
Perform
Jan 17, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Elicio Therapeutics?
  • Does Elicio Therapeutics pay dividends?
  • What sector is Elicio Therapeutics in?
  • What industry is Elicio Therapeutics in?
  • What country is Elicio Therapeutics based in?
  • When did Elicio Therapeutics go public?
  • Is Elicio Therapeutics in the S&P 500?
  • Is Elicio Therapeutics in the NASDAQ 100?
  • Is Elicio Therapeutics in the Dow Jones?
  • When was Elicio Therapeutics's last earnings report?
  • When does Elicio Therapeutics report earnings?
  • Should I buy Elicio Therapeutics stock now?

What is the ticker symbol for Elicio Therapeutics?

The ticker symbol for Elicio Therapeutics is NASDAQ:ELTX

Does Elicio Therapeutics pay dividends?

No, Elicio Therapeutics does not pay dividends

What sector is Elicio Therapeutics in?

Elicio Therapeutics is in the Healthcare sector

What industry is Elicio Therapeutics in?

Elicio Therapeutics is in the Biotechnology industry

What country is Elicio Therapeutics based in?

Elicio Therapeutics is headquartered in United States

When did Elicio Therapeutics go public?

Elicio Therapeutics's initial public offering (IPO) was on February 5, 2021

Is Elicio Therapeutics in the S&P 500?

No, Elicio Therapeutics is not included in the S&P 500 index

Is Elicio Therapeutics in the NASDAQ 100?

No, Elicio Therapeutics is not included in the NASDAQ 100 index

Is Elicio Therapeutics in the Dow Jones?

No, Elicio Therapeutics is not included in the Dow Jones index

When was Elicio Therapeutics's last earnings report?

Elicio Therapeutics's most recent earnings report was on Nov 13, 2024

When does Elicio Therapeutics report earnings?

The next expected earnings date for Elicio Therapeutics is Mar 28, 2025

Should I buy Elicio Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions